RTI Surgical buys Zyga Tech and its SImmetry sacroiliac fusion device, updates 2018 outlook

January 5, 2018 By Fink Densford Leave a Comment

RTI Surgical (NSDQ:RTIX) yesterday announced an agreement to purchase Zyga Technology and its SImmetry sacroiliac joint fusion system and today released updated guidance for 2018 and beyond.

The Alachua, Fla.-based RTI surgical said that Zyga Technology has approximately 30 employees and $4 million in annual revenue, and that it plans to fund the acquisition through a combination of cash and through borrowing under its existing credit facility.

Terms of the deal were not disclosed, and RTI Surgical it expects the deal to close when the Delaware Department of State re-opens as it is currently closed due to inclement weather.

“Acquiring Zyga Technology further advances our strategic transformation focused on reducing complexity, driving operational excellence and accelerating growth. We are increasing our focus on both internal development and external investment, and acquiring Zyga Technology’s innovative minimally invasive treatment both accentuates our robust spine portfolio and opens significant opportunities to accelerate growth. The acquisition provides access to a procedure that has been growing in excess of 20% in recent years and leverages the core competencies of our Spine franchise. We believe it is perfectly aligned with our Spine-focused expansion strategy to pursue niche differentiated products, to gain scale and customer retention and support portfolio pull-through along the way. As part of the RTI team, we believe Zyga has the potential to produce significant growth by gaining market share, growing procedure volume and driving increased adoption. SImmetry is a differentiated product designed to drive fusion and supported by clinical data and, with access to RTI’s larger, sophisticated sales force, we will introduce the system to a much wider surgeon audience,” prez & CEO Camille Farhat said in a prepared release.

The company today laid out its guidance and long term goals for 2018 and beyond, expecting to see revenues for 2018 between $280 million and $290 million, with full year EBITDA between $32 million and $38 million.

“We expect 2018 will be a year of continued progress with the accelerating implementation of our strategic transformation plans. Our guidance reflects the early results of our initiatives and the ongoing investments necessary to produce sustainable profitable growth and improved cash flow,” CEO Farhat said in a prepared statement.

Beyond 2018, the company said it is hopeful to achieve $500 million in revenue within 5 years, with doubled EBITDA margin moving up to more than 20%.

“We expect the initiatives we began to reduce complexity and drive operational excellence in 2017 to produce improving margins and cash flow in our tissue focused operations in the coming years. This expected improvement in financial performance will allow us to fund organic and acquisitive growth in our spine focused operations. We are committed to driving significant financial improvements and increasing long-term shareholder value,” CEO Farhat said in a press release.

Last November, RTI Surgical revealed a warning letter it received from the FDA related to processes used to manufacture its Map3 cellular allogeneic bone graft over issues with the regulatory classification of the product.

RFPi wins FDA nod for non-contact blood flow imaging tech
FDA has cleared RFPi’s iCertainty real-time, noninvasive blood flow and perfusion imaging medical device for use during surgical procedures, the company said. iCertainty is the first medical imaging device to show blood flow without interrupting a surgical procedure or requiring injections, dyes, radiation or direct patient contact, according to the Greenville, N.C. company. Use of iCertainty during surgery… […]
Kyocera buys part of Renovis Surgical
Kyoto, Japan-based Kyocera (TYO:6971) said it will buy the major assets of Renovis Surgical Technologies’ artificial joint and spinal products businesses to expand its U.S. footprint. Kyocera will transfer the assets into a new, wholly owned, California-based company to be named Kyocera Medical Technologies in March 2019. Kyocera manufactures medical products, including artificial joints and dental… […]
Biocoat acquired by 1315 Capital
Biocoat – a Horsham, Pa.–based maker of lubricious hydrophilic coatings for medical devices – said today that healthcare investment firm 1315 Capital has bought it. The deal closed Dec. 20, 2018. Financial terms were not disclosed. Philadelphia-based 1315 Capital provides expansion and growth capital to commercial-stage healthcare services, medical technology, and specialty pharmaceutical companies. Biocoat officials think… […]
Researchers develop speedy 3D printing
University of Michigan researchers said they have developed a 3D printing method that’s up to 100 times faster than conventional 3D printing processes. Rather than building up plastic filaments layer by layer, the new approach lifts complex shapes from a vat of liquid at high speed, potentially allowing manufacturers to produce up to 10,000 objects… […]
MTD Micro Molding named as Plastic News ‘Processor of the Year’ finalist
MTD Micro Molding (Charlton, Mass.) was recently named as one of Plastic News’s 2018 Processor of Year award finalists. MTD Micro Molding was a finalist in 2017 and 2015 as well. Plastic News awards the Processor of the Year award in polymer technologies to companies based on seven criteria: financial performance, quality, customer relations, employee relations,… […]
How AI can detect cervical cancer
Researchers have developed a computer algorithm that they say can analyze digital images of a woman’s cervix and accurately identify precancerous changes that require medical attention. This artificial intelligence approach, called automated visual evaluation, has the potential to revolutionize cervical cancer screening, particularly in low-resource settings. Led by investigators from the National Institutes of Health… […]
The state of M&A in medtech: Here’s what you may not know
Buyouts like Medtronic‘s (NYSE:MDT) $1.7 billion acquisition of Mazor Robotics (NSDQ:MZOR) dominated the headlines in 2018, but industry veteran Shayan Bhattacharyya found himself intrigued by the smaller deals that didn’t make the press. “The things that keep me interested are the deals that are the tuck-in, bolt-on acquisitions,” Bhattacharyya said at DeviceTalks West in Costa Mesa, Calif., last month. (Bhattacharyya… […]
Laird Thermal Systems launches new website
Laird Thermal Systems has launched its new website with advanced engineering tools. The new website allows design engineers to specify, search and select the optimum thermoelectric module, thermoelectric assembly or liquid cooling system for various applications. Laird Thermal Systems also suggests that the website can shorten product design cycles while improving product or system performance… […]
5 top stories that mattered for medtech in 2018
The medical device industry faced some major challenges over the past year, from increased media scrutiny to regulatory uncertainty in both the U.S. and E.U. It’s worth noting, though, that many things have been going right for medtech. More than half of the roughly 100 largest medical device companies in the world saw their stock… […]
Instron touts Torsion Add-On 2.0 for biaxial testing
Instron has launched its new Torsion Add-On 2.0 for universal testing machines. The new add-on is designed to convert axial-only testing machines into biaxial systems that can simulate real-world use of multi-axis loading products. It is able to be added to new or existing Instron 5940 or 5960 series tabletop universal testing machines. Instron’s new… […]
FDA adds back some workers during partial government shutdown
The FDA has resumed several health and safety activities that had been halted by the partial government shutdown, now in its 24th day. In a series of tweets on Sunday, FDA Commissioner Scott Gottlieb, M.D. listed the tasks that the agency has added to “excepted, unpaid work.” “It is not business as usual at FDA.… […]